Secondary metabolites from Ganoderma lucidum and Spongiporus leucomallellus

Ganoderma lucidum contains the steroidester ergosta-7,22-diene-3β-yl pentadecanoate ( 3) while Spongiporus leucomallellus contains the two triterpene acids named spongiporic acids A ( 11) and B ( 12). Antimicrobial activities of spongiporic acid A and cytotoxic activities of 5,8- epi-dioxy-24-methyl...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Phytochemistry (Oxford) 2006, Vol.67 (2), p.202-211
Hauptverfasser:	Campos Ziegenbein, Fernando, Hanssen, Hans-Peter, König, Wilfried A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-Bacterial Agents - chemistry Anti-Bacterial Agents - pharmacology anticarcinogenic activity Antifungal Agents - chemistry Antifungal Agents - pharmacology Biological and medical sciences Biological testing Cell Line, Tumor Cell Proliferation - drug effects Chemical constitution chemical structure Cholesterol - analogs & derivatives Cholesterol - chemistry Cholesterol - pharmacology cultured cells cytotoxicity Ergosta-7,22-diene-3β-yl pentadecanoate esters fruiting bodies Fruiting Bodies, Fungal - chemistry Fruiting Bodies, Fungal - metabolism Fundamental and applied biological sciences. Psychology Ganoderma lucidum General pharmacology Humans Magnetic Resonance Spectroscopy - methods Magnetic Resonance Spectroscopy - standards Medical sciences Microbial Sensitivity Tests Models, Molecular Molecular Conformation oils Pharmacognosy. Homeopathy. Health food Pharmacology. Drug treatments Plant physiology and development Polyporaceae - chemistry Polyporaceae - metabolism Reference Standards Reishi - chemistry Reishi - metabolism secondary metabolites Secosteroids - chemistry Secosteroids - pharmacology spectral analysis spongiporic acid Spongiporic acid A and B Spongiporus leucomallellus stereochemistry Structure-Activity Relationship triterpenoids volatile compounds Volatiles
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!